APRI指数对定西地区感染HCV的供血员肝纤维化的诊断价值

雷成多; 任艳; 郑素军; 任锋; 伍慧丽; 张韶橘; 马世俊; 王泰龄; 段钟平

APRI指数对定西地区感染HCV的供血员肝纤维化的诊断价值

1. 甘肃省定西市第二人民医院传染科
2. 首都医科大学附属北京佑安医院人工肝中心
3. 卫生部中日友好医院病理科

基金项目:

北京高层次卫生人才项目(2011-3-083)；佑安肝病艾滋病基金科研课题(BJYAH-2011-045)；首都卫生发展科研专项项目(首发2011-2018-04)；北京市优秀人才培养资助(D类,2011D003034000022)；

详细信息

中图分类号: R512.63
计量
- 文章访问数: 2878
- HTML全文浏览量: 14
- PDF下载量: 621
- 被引次数: 0
出版历程
- 出版日期: 2013-05-20

Diagnostic value of the APRI index for liver fibrosis in a Chinese patients population with chronic hepatitis C acquired from blood transfusion

Research funding:

摘要

摘要:
目的评价并筛选出适合献血后感染丙型肝炎人群,基于临床常见生化指标的肝纤维化无创预测模型。方法对甘肃省定西地区120例既往供血员丙型肝炎感染患者进行肝穿刺病理肝纤维化评分,检测临床常用生化指标及血清纤维化4项（PCⅢ、CⅣ、HA、LN）,计算APRI指数、Sheth指数、FibroQ指数、FIB-4指数。以肝穿刺病理为金标准,评价上述指标对肝纤维化程度的诊断效能。结果随着肝纤维化程度加重,APRI指数、FibroQ指数、FIB-4指标、PCⅢ、CⅣ、HA的数值增加,其中APRI指数与肝脏穿刺病理分期的相关性良好（r=0.446,P<0.001）,对明显肝纤维化（≥S2）的诊断效能最高,曲线下面积（AUC）为0.722,其诊断敏感度为57.1%,特异性为78.2%。结论 APRI指数对肝纤维化≥S2有一定的鉴别作用,可作为未行肝穿刺病理检查患者的一个有益补充。
- APRI指数 /
- 肝炎,丙型 /
- 肝硬化
Abstract:
Objective To evaluate the diagnostic efficacy of various newly developed non-invasive fibrotic predictive models based on measurements of common biochemical indices in a group of ethnic Chinese patients with long-standing chronic hepatitis C (CHC) infection acquired by transfusion.Methods Between July 2010 and June 2011, 120 of the monitored residents of Dingxi District of Gansu Province who had acquired hepatitis C infection via the regional practice of untested whole blood or plasma transfusion during the years of 1992-1995 were recruited for the current study.Each participant underwent liver biopsy for histological evaluation of liver fibrosis (S1-S4 progressive stages, from mild fibrosis to early cirrhosis) .Each participant also provided serum samples for biochemical measurement of fibrotic indicators, including hyaluronic acid (HA) , type Ⅲ procollagen protein (PCⅢ) , laminin (LN) , and type IV collagen (CⅣ) .In addition, aspartate aminotransferase (AST) , platelet count (PLT) , alanine aminotransferase (ALT) , prothrombin time (PT) , and international normalized ratio (INR) were measured to calculate the various non-invasive fibrotic predictive models: AST-to-PLT ratio index (APRI) , the Sheth index (AST/ALT) , the FibroQ index (10×[ (age×AST×PT INR) / (ALT×PLT]) , and the FIB-4 index ([age×AST) / (PLT×ALT1/2) ]) .Using the pathologic results as the reference standards, the diagnostic efficacies of these four non-invasive fibrotic predictive models were evaluated by Spearman's rank correlation coefficient.Accuracies of the four were compared by constructing receiver operating characteristic (ROC) curves and analyzing their sensitivities, specificities and area under the curves (AUCs) .Results The APRI, FibroQ and FIB-4 indexes, and the levels of PCⅢ, CⅣ, and HA increased in conjunction with progressive stages of liver fibrosis.However, only the APRI showed significant correlation to liver fibrosis stage (r=0.446, P<0.001) .The APRI index also had a better ability for distinguishing the moderatefibrosis stage from the severe fibrosis stage, as indicated by an AUC of 0.722, diagnostic sensitivity of 57.1%, and specificity of 78.2%.Conclusion APRI may be an effective and less traumatic alternative approach to surgical biopsy for diagnosing fibrosis, especially at stages greater than S2, in ethnic Chinese with CHC.
- aspartate aminotransferase-to-platelet ratio index /
- hepatitis C /
- liver cirrhosis

HTML全文

参考文献(19)

[1]Rockey DC, Caldwell SH, Goodman ZD, et al.American Associa-tion for the Study of LiverDiseases.Liver biopsy[J].Hepatology, 2009, 49 (3) :1017-1044.

[2]Bonacini M, Hadi G, Govindarajan S, et al.Utility of a discrimi-nant score for diagnosing advanced fibrosis or cirrhosis in patientswith chronic hepatitis C virus infection[J].Am J Gastroenterol, 1997, 92 (8) :1302-1304.

[3]Pohl A, Behling C, Oliver D, et al.Serum aminotransferase levelsand platelet counts as predictors of degree of fibrosis in chronic hep-atitis C virus infection[J].Am J Gastroenterol, 2001, 96 (11) :3142-3146.

[4]Forns X, Ampurdanès S, Llovet JM, et al.Identification of chronichepatitis C patients without hepatic fibrosis by a simple predictivemodel[J].Hepatology, 2002, 36 (4 Pt 1) :986-992.

[5]Testa R, Testa E, Giannini E, et al.Noninvasive ratio indexes toevaluate fibrosis staging in chronic hepatitis C:role of plateletcount/spleen diameter ratio index[J].J Intern Med, 2006, 260 (2) :142-150.

[6]Islam S, Antonsson L, Westin J, et al.Cirrhosis in hepatitis C vi-rus-infected patients can be excluded using an index of standardbiochemical serum markers[J].Scand J Gastroenterol, 2005, 40 (7) :867-872.

[7]Poynard T, AubertA, Bedossa P, et al.A simple biological indexfor detection of alcoholic liver disease in drinkers[J].Gastroenter-ology, 1991, 100 (5 Pt1) :1397-1402.

[8]Zhang WS, Wang BE, Wang TL, et al.Noninvasive assessment of liverfibrosis in chronic hepatitis B using a predictive model[J].Chin JHepatol, 2006, 14 (3) :169-173. (in Chinese) 张文胜, 王宝恩, 王泰龄, 等.慢性乙型肝炎肝纤维化无创性预测模型的建立[J].中华肝脏病杂志, 2006, 14 (3) :169-173.

[9]Hui AY, Chan HL, Wong VW, et al.Identification of chronic hep-atitis B patients without significant liver fibrosis by a simple nonin-vasive predictive model[J].Am J Gastroenterol, 2005, 100 (3) :616-623.

[10]Zhou K, Zheng RD, Xian JC, et al.Building a noninvasive diag-nostic modle based on conventional laboratory markers to predict liv-er fibrosis[J].Chin hepatol, 2008, 13 (5) :362-367. (in Chi-nese) 周琨, 郑瑞丹, 咸建春, 等.从常规指标中建立肝纤维化非创伤性预测模型[J].肝脏, 2008, 13 (5) :362-367.

[11]Poynard T, Ngo Y, Perazzo H, et al.Prognostic value of liver fibro-sis biomarkers:a meta-analysis[J].Gastroenterol Hepatol (NY) , 2011, 7 (7) :445-454.

[12]Cao YN, Li SL.Research in the progress of non-invasive diagno-sis of liver fibrosis[J].J Clin Hepotal, 2011, 27 (2) :214-217. (in Chinese) 曹玉宁, 李森林.肝纤维化无创诊断的研究进展[J].临床肝胆病杂志, 2011, 27 (2) :214-217.

[13]European Association for the Study of the Liver.EASL ClinicalPractice Guidelines:management of hepatitis C virus infection[J].J Hepatol, 2011, 55 (2) :245-264.

[14]Shaheen AA, Myers RP.Diagnostic accuracy of the aspartate amin-otransferase-to-platelet ratio index for the prediction of hepatitisC-related fibrosis:a systematic review[J].Hepatology, 2007, 46 (3) :912-921.

[15]Amorim TG, Staub GJ, Lazzarotto C, et al.Validation and compar-ison of simple noninvasive models for the prediction of liver fibrosisin chronic hepatitis C[J].Ann Hepatol, 2012, 11 (6) :855-861.

[16]Zhao YL, Zhao JM, Zhou GD, et al.Diagnostic value of AAR andAPRI for liver fibrosis in adult patient with chronic hepatitis C[J].Infect Dis info, 2010, 23 (2) :101-103. (in Chinese) 赵雨来, 赵景民, 周光德, 等.AAR和APRI对成年慢性丙型肝炎患者肝纤维化的诊断价值[J].传染病信息, 2010, 23 (2) :101-103.

[17]Chen GF, Li B, Chen SH.Research progress in non-invasive di-agnosis of hepatic fibrosis[J].J Med Res, 2011, 40 (4) :15-18. (in Chinese) 陈国风, 李冰, 陈松海.肝纤维化无创性诊断的研究进展[J].医学研究杂志, 2011, 40 (4) :15-18.

[18]Shaheen AA, Wan AF, Myers RP.FibroTest and FibroScan for theprediction of hepatitis C-related fibrosis:a systematic review of di-agnostic test accuracy[J].Am J Gastroenterol, 2007, 102 (11) :2589-2600.

[19]Hsieh YY, Tung SY, Lee IL, et al.FibroQ:an easy and usefulnoninvasive test for predicting liver fibrosis in patients with chronicviral hepatitis[J].Chang Gung Med J, 2009, 32 (6) :614-622.

施引文献

资源附件(0)

访问统计